Alzheimer’s disease

Calls for input into dementia guidelines

The first major overhaul of Australia’s dementia guidelines since 2016 is now open for public consultation, with Monash University seeking…

Air pollution linked to Alzheimer’s disease

Air pollution has long been linked to heart and lung disease. But a large US study suggests it may also…

Australia faces growing dementia challenge

New data released by Dementia Australia reveals that the impact of dementia spans all age groups, with an estimated 29,000…

Exercising in mid and later life can reduce dementia risk – new study

Does exercising at any age help reduce your risk of dementia? Or only when you’re young? And what if you…

Design transforms dementia care

Far from being a mere backdrop, thoughtful and compassionate design can have a significant impact on the independence, safety, and…

ABS confirms dementia as leading cause of death

In 2024, over 17,500 deaths were from dementia, including Alzheimer’s disease, which accounted for 9.4 per cent of all deaths…

Baby dolls bring calm to residents with dementia

Sometimes referred to as “doll therapy” or “empathy dolls”, but more accurately known as “child representation”, the use of cuddly…

My journey as a dementia carer

Jessie Halls became her husband's carer when he was diagnosed with early onset Alzheimer’s disease at just 62 years old.…

Dementia exposes older people to increased abuse

Concerns about the exploitation of older Australians have erupted after a Sydney real estate agent purchased a home at a…

Lecanemab approved by TGA

A new treatment for early to mild Alzheimer’s disease has been registered with Australia’s pharmaceutical regulator in a major development…

Australians behind brain health breakthroughs

Australian scientists are on the brink of massive breakthroughs in brain health. New treatments, early screening, and even a potential…

Dementia now number-one killer

Dementia has become the leading cause of death in Australia and more than one million people are expected to be living…

‘Brain cleaning’ lowers risk of dementia

Disrupted sleep may hinder your brain's waste disposal system and slow the clearance of waste products or toxins from the…

No PBS for new Alzheimer’s therapy

The Pharmaceutical Benefits Advisory Committee has rejected an application for a newly approved Alzheimer’s treatment to be included on the…

New Alzheimer’s drug works 3x faster

A new Alzheimer’s drug has been hailed as a major breakthrough after clinical trials showed it could clear the harmful…

Don’t Demention It: How one rural support group grew into something bigger

In a rural farming community like ours, where resources can sometimes feel out of reach, the need for support networks…

Two of the best ways to respond to people with dementia who think they are in a different time or place

Approximately one quarter of hospital beds in acute wards – wards for patients who need close care for a sudden…

TGA doubles down on rejection of Alzheimer’s drug

The Australian Therapeutic Goods Administration (TGA) has confirmed its decision not to register Alzheimer's disease drug lecanemab (LEQEMBI). Lecanemab is…

Bacteria in your mouth may hold clues to your brain health and dementia risk – new study

Joanna L'Heureux, University of Exeter Could the bacteria in your mouth predict whether you are at risk of dementia? Emerging…

Dementia-prevention program could be rolled out nationally: Aus study

Australian researchers have shown that delivering lifestyle intervention programs to older people remotely, results in "significantly better cognition." The Maintain…

10-year National Dementia Action Plan announced

The Albanese government has released its National Dementia Action Plan 2024-2034, aimed at creating a nation that's more “dementia inclusive.”…

What is ‘doll therapy’ for people with dementia? And is it backed by science?

The way people living with dementia experience the world can change as the disease progresses. Their sense of reality or…

Dementia drug rejected by TGA

The Therapeutic Goods Administration (TGA) has decided not to register Alzheimer's drug lecanemab (LEQEMBI) on the basis that "the demonstrated…

“Shiny new treatment:” High cost means new Alzheimer’s drugs not available to all

While the approval of Alzheimer's disease modifying treatments like donanemab and lecanemab (Leqembi) continues to be hotly debated internationally, a…

FDA approves drug for early symptomatic Alzheimer’s disease

The U.S. Food and Drug Administration (FDA) has approved the Kisunla (donanemab-azbt) injection for the treatment of Alzheimer’s disease after months of…